Charles Explorer logo
🇬🇧

Identification of novel candidate proteins for anti-cancer activity of olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.

Publication at First Faculty of Medicine, Faculty of Mathematics and Physics |
2001

Abstract

Altered cell control in the rb and p53 pathwazs has emerged as a recurring and underlaying mechanism of most cancer cells.